Brief: Ascelia Pharma Resolves On Convertibles Issue Of SEK 7.5 Mln
13/09/2024 12:38
Sept 13 (Reuters) - Ascelia Pharma AB ACELP.ST :
* RESOLVES ON A DIRECTED ISSUE OF CONVERTIBLES OF SEK 7.5 MILLION
* FENJA CAPITAL HAS RIGHT TO REQUEST CONVERSION OF NEW CONVERTIBLES INTO ORDINARY SHARES AT
A
CONVERSION PRICE OF SEK 3.38 PER SHARE
* CONVERSION PRICE CORRESPONDS TO 200 PER CENT OF SUBSCRIPTION PRICE PER SHARE IN RIGHTS
ISSUE
* PAYMENT FOR NEW CONVERTIBLES WILL BE MADE BY OFFSETTING AGAINST EXISTING CONVERTIBLES
Source text for Eikon: ID:nMFN2Gbnr0
Further company coverage: ACELP.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))